Institutions & Industry

The National Institute on Aging is the primary United States government agency dedicated to biomedical, clinical, behavioral, and social research on aging.

The Buck Institute for Research on Aging conducts basic and translational research into the biological mechanisms of aging, operating as an independent.

Altos Labs is a biotechnology company researching cellular rejuvenation through epigenetic and cellular reprogramming, the process of resetting adult.

Calico is a biotechnology company majority owned by Alphabet Inc.

Epigenetic clocks are statistical models that estimate a person's biological age from patterns of DNA methylation, a chemical modification of DNA that changes in predictable ways over the lifespan.

Human Longevity, Inc. is a genomics and precision medicine company that combines whole genome sequencing with advanced imaging, metabolomic, microbiomic.

Blue Zones is both a demographic hypothesis and a commercial brand.

Longevity biotech investing spans a spectrum from dedicated specialist funds to large generalist venture firms and individual billionaire backers entering the space opportunistically.

The Methuselah Foundation is a US 501(c)(3) nonprofit, based in Springfield, Virginia and led by co-founder and CEO David Gobel, created to accelerate research into extending healthy human lifespan.

SENS Research Foundation was built around Aubrey de Grey's Strategies for Engineered Negligible Senescence framework, which divides the biological damage of aging into seven categories.

Unity Biotechnology was one of the first venture-backed companies built specifically around the senescent-cell hypothesis of aging.

Longevity clinics offer paying members, typically for annual membership fees ranging from several thousand to over twenty thousand dollars.